The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Management strategies and future directions for systemic lupus erythematosus in adults
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disease characterised by the loss of self-tolerance and formation of nuclear autoantigens and immune complexes resulting in inflammation of multiple organs. The clinical presentation of SLE is heterogeneous, can involve one or more organs, including the skin, kidneys, joints, and nervous system, and take a chronic or relapsing and remitting disease course. SLE is most common in women and in those of non-white ethnicity. Because of the multitude of presentations, manifestations, and serological abnormalities in patients with SLE, diagnosis can be challenging. Therapeutic approaches predominantly involve immunomodulation and immunosuppression and are targeted to the specific organ manifestation, with the aim of achieving low disease activity. Despite many treatment advances and improved diagnostics, SLE continues to cause substantial morbidity and premature mortality. Current management strategies, although helpful, are limited by high failure rates and toxicity. An overreliance on corticosteroid therapy contributes to much of the long-term organ damage. In this Seminar, we outline the classification criteria for SLE, current treatment strategies and medications, the evidence supporting their use, and explore potential future therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Petri, M., Orbai, A., Alarcón, G. S., Gordon, C., Merrill, J. T., Fortin, P. R., Bruce, I. N., Isenberg, D., Wallace, D. J., Nived, O., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34473 · Cited by 5,322
Self-citationDerivation of the sledai. A disease activity index for lupus patients
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., Austin, A., Bell, A., Bloch, D. A., Corey, P. N., Decker, J. L., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350606 · Cited by 4,570
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
Arbuckle, M. R., McClain, M. T., Rubertone, M. V., Scofield, R. H., Dennis, G. J., James, J. A., & Harley, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021933 · Cited by 2,578
Navarra, S. V., Guzmán, R. M., Gallacher, A. E., Hall, S., Levy, R. A., Jimenez, R. E., Li, E. K.-M., Thomas, M., Kim, H.-Y., León, M. G., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61354-2 · Cited by 2,074
Self-citationThe Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited
Weening, J. J., D’Agati, V. D., Schwartz, M. M., Seshan, S. V., Alpers, C. E., Appel, G. B., Balow, J. E., Bruijn, J. A., Cook, T., Ferrario, F., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000108969.21691.5d · Cited by 2,008
Furie, R., Petri, M., Zamani, O., Cervera, R., Wallace, D. J., Tegzová, D., Sanchez-Guerrero, J., Schwarting, A., Merrill, J. T., Chatham, W. W., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30613 · Cited by 1,683
Self-citationHahn, B. H., McMahon, M. A., Wilkinson, A., Wallace, W. D., Daikh, D. I., FitzGerald, J. D., Karpouzas, G. A., Merrill, J. T., Wallace, D. J., Yazdany, J., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21664 · Cited by 1,463
Rovin, B. H., Furie, R., Latinis, K., Looney, R. J., Fervenza, F. C., Sanchez‐Guerrero, J., Maciuca, R., Zhang, D., Garg, J. P., Brunetta, P., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34359 · Cited by 1,461
Merrill, J. T., Neuwelt, C. M., Wallace, D. J., Shanahan, J. C., Latinis, K. M., Oates, J. C., Utset, T. O., Gordon, C., Isenberg, D. A., Hsieh, H., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27233 · Cited by 1,409
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
Schwartz, D. M., Kanno, Y., Villarino, A., Ward, M., Gadina, M., & O'Shea, J. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.201 · Cited by 1,266
Mortality in systemic lupus erythematosus
Bernatsky, S., Boivin, J. ‐., Joseph, L., Manzi, S., Ginzler, E., Gladman, D. D., Urowitz, M., Fortin, P. R., Petri, M., Barr, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21955 · Cited by 1,181
Self-citationMycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
Ginzler, E. M., Dooley, M. A., Aranow, C., Kim, M. Y., Buyon, J., Merrill, J. T., Petri, M., Gilkeson, G. S., Wallace, D. J., Weisman, M. H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043731 · Cited by 1,128
Self-citationHoussiau, F. A., Vasconcelos, C., D'Cruz, D., Sebastiani, G. D., Garrido, E. D. R., Danieli, M. G., Abramovicz, D., Blockmans, D., Mathieu, A., Direskeneli, H., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10461 · Cited by 1,077
Bertsias, G. K., Tektonidou, M., Amoura, Z., Aringer, M., Bajema, I., Berden, J. H. M., Boletis, J., Cervera, R., Dörner, T., Doria, A., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201940 · Cited by 1,007
Andreoli, L., Bertsias, G. K., Agmon-Levin, N., Brown, S., Cervera, R., Costedoat-Chalumeau, N., Doria, A., Fischer-Betz, R., Forger, F., Moraes-Fontes, M. F., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209770 · Cited by 945
Han, J.-W., Zheng, H.-F., Cui, Y., Sun, L.-D., Ye, D.-Q., Hu, Z., Xu, J.-H., Cai, Z.-M., Huang, W., Zhao, G.-P., et al. (2009) · Nature Genetics · doi:10.1038/ng.472 · Cited by 936
Association of Systemic Lupus Erythematosus with C8orf13–BLK and ITGAM–ITGAX
Hom, G., Graham, R. R., Modrek, B., Taylor, K. E., Ortmann, W., Garnier, S., Lee, A. T., Chung, S. A., Ferreira, R. C., Pant, P. V. K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707865 · Cited by 914
Self-citationFurie, R., Khamashta, M., Merrill, J. T., Werth, V. P., Kalunian, K., Brohawn, P., Illei, G. G., Drappa, J., Wang, L., Yoo, S., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.39962 · Cited by 882
Gateva, V., Sandling, J. K., Hom, G., Taylor, K. E., Chung, S. A., Sun, X., Ortmann, W., Kosoy, R., Ferreira, R. C., Nordmark, G., et al. (2009) · Nature Genetics · doi:10.1038/ng.468 · Cited by 810
Self-citationDefinition and initial validation of a Lupus Low Disease Activity State (LLDAS)
Franklyn, K., Lau, C. S., Navarra, S. V., Louthrenoo, W., Lateef, A., Hamijoyo, L., Wahono, C. S., Chen, S. L., Jin, O., Morton, S., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207726 · Cited by 764
Bertsias, G. K., Ioannidis, J. P. A., Aringer, M., Bollen, E., Bombardieri, S., Bruce, I. N., Cervera, R., Dalakas, M., Doria, A., Hanly, J. G., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.130476 · Cited by 742
Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy
Marmor, M. F., Kellner, U., Lai, T. Y. Y., Lyons, J. S., & Mieler, W. F. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2010.11.017 · Cited by 710
The Risk of Toxic Retinopathy in Patients on Long-term Hydroxychloroquine Therapy
Melles, R. B., & Marmor, M. F. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.3459 · Cited by 680
The frequency and outcome of lupus nephritis: results from an international inception cohort study
Hanly, J. G., O’Keeffe, A. G., Su, L., Urowitz, M. B., Romero-Diaz, J., Gordon, C., Bae, S.-C., Bernatsky, S., Clarke, A. E., Wallace, D. J., et al. (2016) · Rheumatology · doi:10.1093/rheumatology/kev311 · Cited by 647
Self-citationMycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
Dooley, M. A., Jayne, D., Ginzler, E. M., Isenberg, D., Olsen, N. J., Wofsy, D., Eitner, F., Appel, G. B., Contreras, G., Lisk, L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014460 · Cited by 642
Isenberg, D. A., Rahman, A., Allen, E., Farewell, V., Akil, M., Bruce, I. N., D'Cruz, D., Griffiths, B., Khamashta, M., Maddison, P., et al. (2005) · Rheumatology · doi:10.1093/rheumatology/keh624 · Cited by 636
Gourley, M. F., Austin III, H. A., Scott, D., Yarboro, C. H., Vaughan, E. M., Muir, J., Boumpas, D. T., Klippel, J. H., Balow, J. E., & Steinberg, A. D. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-7-199610010-00003 · Cited by 607
Crow, Y. J., Chase, D. S., Lowenstein Schmidt, J., Szynkiewicz, M., Forte, G. M. A., Gornall, H. L., Oojageer, A., Anderson, B., Pizzino, A., Helman, G., et al. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36887 · Cited by 595
Tektonidou, M. G., Dasgupta, A., & Ward, M. M. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39594 · Cited by 582
Sun, L., Akiyama, K., Zhang, H., Yamaza, T., Hou, Y., Zhao, S., Xu, T., Le, A., & Shi, S. (2009) · Stem Cells · doi:10.1002/stem.68 · Cited by 580
Distinctive cutaneous subsets in the spectrum of lupus erythematosus
Gilliam, J. N., & Sontheimer, R. D. (1981) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(81)80261-7 · Cited by 533
Hydroxychloroquine in lupus pregnancy
Clowse, M. E. B., Magder, L., Witter, F., & Petri, M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22159 · Cited by 529
Self-citationAlarcón, G. S., McGwin, G., Bertoli, A. M., Fessler, B. J., Calvo-Alén, J., Bastian, H. M., Vilá, L. M., & Reveille, J. D. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.068676 · Cited by 528
Wallace, D. J., Furie, R. A., Tanaka, Y., Kalunian, K. C., Mosca, M., Petri, M. A., Dörner, T., Cardiel, M. H., Bruce, I. N., Gomez, E., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31363-1 · Cited by 513
Self-citationFeldman, C. H., Hiraki, L. T., Liu, J., Fischer, M. A., Solomon, D. H., Alarcón, G. S., Winkelmayer, W. C., & Costenbader, K. H. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37795 · Cited by 487
Sun, L., Wang, D., Liang, J., Zhang, H., Feng, X., Wang, H., Hua, B., Liu, B., Ye, S., Hu, X., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27548 · Cited by 475
Izmirly, P. M., Costedoat-Chalumeau, N., Pisoni, C. N., Khamashta, M. A., Kim, M. Y., Saxena, A., Friedman, D., Llanos, C., Piette, J.-C., & Buyon, J. P. (2012) · Circulation · doi:10.1161/circulationaha.111.089268 · Cited by 456
Condon, M. B., Ashby, D., Pepper, R. J., Cook, H. T., Levy, J. B., Griffith, M., Cairns, T. D., & Lightstone, L. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202844 · Cited by 454
Somers, E. C., Marder, W., Cagnoli, P., Lewis, E. E., DeGuire, P., Gordon, C., Helmick, C. G., Wang, L., Wing, J. J., Dhar, J. P., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38238 · Cited by 449
Alarcón‐Segovia, D., Alarcón‐Riquelme, M. E., Cardiel, M. H., Caeiro, F., Massardo, L., Villa, A. R., Pons‐Estel, B. A., & (GLADEL), O. B. O. T. G. L. D. E. D. L. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20999 · Cited by 421
Stohl, W., Schwarting, A., Okada, M., Scheinberg, M., Doria, A., Hammer, A. E., Kleoudis, C., Groark, J., Bass, D., Fox, N. L., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40049 · Cited by 420
van Vollenhoven, R. F., Petri, M. A., Cervera, R., Roth, D. A., Ji, B. N., Kleoudis, C. S., Zhong, Z. J., & Freimuth, W. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200937 · Cited by 411
Self-citationManzi, S., Sánchez-Guerrero, J., Merrill, J. T., Furie, R., Gladman, D., Navarra, S. V., Ginzler, E. M., D'Cruz, D. P., Doria, A., Cooper, S., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200831 · Cited by 411
Self-citationMultitarget Therapy for Induction Treatment of Lupus Nephritis: A Randomized Trial
Liu, Z., Zhang, H., Liu, Z., Xing, C., Fu, P., Ni, Z., Chen, J., Lin, H., Liu, F., He, Y., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1030 · Cited by 396
Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure
James, J. A., Neas, B. R., Moser, K. L., Hall, T., Bruner, G. R., Sestak, A. L., & Harley, J. B. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200105)44:5<1122::aid-anr193>3.0.co;2-d · Cited by 390
Lockshin, M. D., Kim, M., Laskin, C. A., Guerra, M., Branch, D. W., Merrill, J., Petri, M., Porter, T. F., Sammaritano, L., Stephenson, M. D., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34402 · Cited by 388
Self-citationPredictors of major infections in systemic lupus erythematosus
Ruiz-Irastorza, G., Olivares, N., Ruiz-Arruza, I., Martinez-Berriotxoa, A., Egurbide, M.-V., & Aguirre, C. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2764 · Cited by 374
Alexander, T., Sarfert, R., Klotsche, J., Kühl, A. A., Rubbert-Roth, A., Lorenz, H.-M., Rech, J., Hoyer, B. F., Cheng, Q., Waka, A., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206016 · Cited by 368
van Vollenhoven, R., Voskuyl, A., Bertsias, G., Aranow, C., Aringer, M., Arnaud, L., Askanase, A., Balážová, P., Bonfa, E., Bootsma, H., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209519 · Cited by 367
Self-citationThe Incidence and Prevalence of Systemic Lupus Erythematosus, 2002–2004: The Georgia Lupus Registry
Lim, S. S., Bayakly, A. R., Helmick, C. G., Gordon, C., Easley, K. A., & Drenkard, C. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38239 · Cited by 359
van Vollenhoven, R. F., Hahn, B. H., Tsokos, G. C., Wagner, C. L., Lipsky, P., Touma, Z., Werth, V. P., Gordon, R. M., Zhou, B., Hsu, B., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32167-6 · Cited by 330
Chakravarty, E. F., Bush, T. M., Manzi, S., Clarke, A. E., & Ward, M. M. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22641 · Cited by 319
Vitali, C., Bencivelli, W., Isenberg, D. A., Smolen, J. S., Snaith, M. L., Sciuto, M. E., Neri, R., & Bombardieri, S. (1992) · PubMed · Cited by 317
Kuo, C.-F., Grainge, M. J., Valdes, A. M., See, L.-C., Luo, S.-F., Yu, K.-H., Zhang, W., & Doherty, M. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.3528 · Cited by 310
Costedoat‐Chalumeau, N., Amoura, Z., Hulot, J., Hammoud, H. A., Aymard, G., Cacoub, P., Francès, C., Wechsler, B., Huong, D. L. T., Ghillani, P., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22156 · Cited by 309
Nonmyeloablative Hematopoietic Stem Cell Transplantation for Systemic Lupus Erythematosus
Burt, R. K. (2006) · JAMA · doi:10.1001/jama.295.5.527 · Cited by 290
Magder, L. S., & Petri, M. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws130 · Cited by 289
Self-citationGinzler, E. M., Wax, S., Rajeswaran, A., Copt, S., Hillson, J., Ramos, E., & Singer, N. G. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3738 · Cited by 284
McCune, W. J., Golbus, J., Zeldes, W., Bohlke, P., Dunne, R., & Fox, D. A. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806023182203 · Cited by 282
van den Borne, B. E. E. M., Dijkmans, B. A. C., de ROOY, H. H., le Cessie, S., & Verweij, C. (1997) · PubMed · Cited by 281
Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort
Namjou, B., Kothari, P. H., Kelly, J. A., Glenn, S. B., Ojwang, J. O., Adler, A., Alarcón-Riquelme, M. E., Gallant, C. J., Boackle, S. A., Criswell, L. A., et al. (2011) · Genes & Immunity · doi:10.1038/gene.2010.73 · Cited by 281
Self-citationMorbidity of systemic lupus erythematosus: Role of race and socioeconomic status
Petri, M., Perez-Gutthann, S., Longenecker, J. C., & Hochberg, M. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90151-m · Cited by 278
Self-citationMok, C. C., Kwok, C. L., Ho, L. Y., Chan, P. T., & Yip, S. F. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30277 · Cited by 247
Díaz-Lagares, C., Croca, S., Sangle, S., Vital, E. M., Catapano, F., Martínez-Berriotxoa, A., García-Hernández, F., Callejas-Rubio, J.-L., Rascón, J., D'Cruz, D., et al. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.10.009 · Cited by 246
Sacre, K., Criswell, L. A., & McCune, J. M. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3895 · Cited by 246
Traynor, A. E., Schroeder, J., Rosa, R. M., Cheng, D., Stefka, J., Mujais, S., Baker, S., & Burt, R. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02627-1 · Cited by 245
Merrill, J. T., Wallace, D. J., Wax, S., Kao, A., Fraser, P. A., Chang, P., Isenberg, D., & on behalf of the ADDRESS II Investigators (2018) · Arthritis & Rheumatology · doi:10.1002/art.40360 · Cited by 244
Environmental exposures and the development of systemic lupus erythematosus
Barbhaiya, M., & Costenbader, K. H. (2016) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000318 · Cited by 241
Jacob, C. O., Zhu, J., Armstrong, D. L., Yan, M., Han, J., Zhou, X. J., Thomas, J. A., Reiff, A., Myones, B. L., Ojwang, J. O., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901181106 · Cited by 240
An, J., Woodward, J. J., Sasaki, T., Minie, M., & Elkon, K. B. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402793 · Cited by 239
Prednisone, Lupus Activity, and Permanent Organ Damage
THAMER, M., HERNÁN, M. A., ZHANG, Y., COTTER, D., & PETRI, M. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.080828 · Cited by 232
Self-citationAutologous stem cell transplantation for systemic lupus erythematosus
Jayne, D., & Tyndall, A. (2004) · Lupus · doi:10.1191/0961203304lu1027oa · Cited by 225
Mok, C. C., Ying, K. Y., Yim, C. W., Siu, Y. P., Tong, K. H., To, C. H., & Ng, W. L. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206456 · Cited by 220
Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction
Furumoto, Y., Smith, C. K., Blanco, L., Zhao, W., Brooks, S. R., Thacker, S. G., Zarzour, A., Sciumè, G., Tsai, W. L., Trier, A. M., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.39818 · Cited by 217
Mok, C. C., Ho, L. Y., Fong, L. S., & To, C. H. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201393 · Cited by 213
Petri, M. (2011) · Current Rheumatology Reports · doi:10.1007/s11926-010-0141-y · Cited by 206
Self-citationSurviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus
Borchers, A. T., Keen, C. L., Shoenfeld, Y., & Gershwin, M. E. (2004) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.04.002 · Cited by 206
Cutaneous lupus erythematosus: Update of therapeutic options
Kuhn, A., Ruland, V., & Bonsmann, G. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.06.018 · Cited by 203
Kasitanon, N., Fine, D. M., Haas, M., Magder, L. S., & Petri, M. (2006) · Lupus · doi:10.1191/0961203306lu2313oa · Cited by 197
Self-citationKuhn, A., Aberer, E., Bata‐Csörgő, Z., Caproni, M., Dreher, A., Frances, C., Gläser, R., Klötgen, H. ‐., Landmann, A., Marinovic, B., et al. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14053 · Cited by 192
Durcan, L., Clarke, W. A., Magder, L. S., & Petri, M. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.150379 · Cited by 190
Self-citationWillis, R., Seif, A., McGwin, G., Martinez-Martinez, L., González, E., Dang, N., Papalardo, E., Liu, J., Vilá, L., Reveille, J., et al. (2012) · Lupus · doi:10.1177/0961203312437270 · Cited by 186
Carneiro, J. R. I., & Sato, E. I. (1999) · PubMed · Cited by 178
Petri, M., & Magder, L. S. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40571 · Cited by 175
Self-citationda Silva, J. C., Mariz, H. A., da Rocha Júnior, L. F., Santana de Oliveira, P. S., Dantas, A. T., Duarte, A. L. B. P., da Rocha Pitta, I., Galdino, S. L., & da Rocha Pitta, M. G. (2013) · Clinics · doi:10.6061/clinics/2013(06)07 · Cited by 172
Arnaud, L., Fagot, J.-P., Mathian, A., Paita, M., Fagot-Campagna, A., & Amoura, Z. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.08.034 · Cited by 168
Fortin, P. R., Abrahamowicz, M., Ferland, D., Lacaille, D., Smith, C. D., Zummer, M., & Canadian Network For Improved Outcomes in Systemic Lupus Erythematosus (2008) · Arthritis Care & Research · doi:10.1002/art.24068 · Cited by 165
Chang, D., Lan, J., Lin, H., & Luo, S. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10615 · Cited by 165
Lima, G. L., Paupitz, J., Aikawa, N. E., Takayama, L., Bonfa, E., & Pereira, R. M. R. (2016) · Arthritis Care & Research · doi:10.1002/acr.22621 · Cited by 165
The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus
Kraaij, T., Kamerling, S. W. A., de Rooij, E. N. M., van Daele, P. L. A., Bredewold, O. W., Bakker, J. A., Bajema, I. M., Scherer, H. U., Toes, R. E. M., Huizinga, T. J. W., et al. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.03.003 · Cited by 164
Petri, M. A., Lahita, R. G., Van Vollenhoven, R. F., Merrill, J. T., Schiff, M., Ginzler, E. M., Strand, V., Kunz, A., Gorelick, K. J., & Schwartz, K. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10364 · Cited by 159
Self-citationGinzler, E. M., Wofsy, D., Isenberg, D., Gordon, C., Lisk, L., & Dooley, M. (2010) · Arthritis & Rheumatism · doi:10.1002/art.25052 · Cited by 159
Petri, M., Bello, K. J., Fang, H., & Magder, L. S. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37953 · Cited by 158
Self-citationJarukitsopa, S., Hoganson, D. D., Crowson, C. S., Sokumbi, O., Davis, M. D. P., Michet, C. J., Matteson, E. L., Kremers, H. M., & CHOWDHARY, V. R. (2014) · Arthritis Care & Research · doi:10.1002/acr.22502 · Cited by 158
GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region
Armstrong, D. L., Zidovetzki, R., Alarcón-Riquelme, M. E., Tsao, B. P., Criswell, L. A., Kimberly, R. P., Harley, J. B., Sivils, K. L. M., Vyse, T. J., Gaffney, P. M., et al. (2014) · Genes and Immunity · doi:10.1038/gene.2014.23 · Cited by 157
López, P., Mozo, L., Gutiérrez, C., & Suárez, A. (2003) · Lupus · doi:10.1191/0961203303lu469xx · Cited by 155
High‐dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus
Petri, M., Jones, R. J., & Brodsky, R. A. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10752 · Cited by 148
Self-citationvan Vollenhoven, R. F., Park, J. L., Genovese, M. C., West, J. P., & McGuire, J. L. (1999) · Lupus · doi:10.1191/096120399678847588 · Cited by 144
Petri, M., Mease, P. J., Merrill, J. T., Lahita, R. G., Iannini, M. J., Yocum, D. E., Ginzler, E. M., Katz, R. S., Gluck, O. S., Genovese, M. C., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20427 · Cited by 144
Self-citationFerucci, E. D., Johnston, J. M., Gaddy, J. R., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38720 · Cited by 144
Tacrolimus use in lupus nephritis: A systematic review and meta-analysis
Hannah, J. R., Casian, A., & D’Cruz, D. P. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.09.006 · Cited by 142
Cutaneous lupus erythematosus: Update of therapeutic options
Kuhn, A., Ruland, V., & Bonsmann, G. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.06.017 · Cited by 123
Remission in systemic lupus erythematosus: durable remission is rare
Wilhelm, T. R., Magder, L. S., & Petri, M. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209489 · Cited by 114
Self-citationDrenkard, C., Villa, A. R., Alarcón-Segovia, D., & Pérez-Vázquez, M. (1994) · PubMed · Cited by 108
Molokhia, M., McKeigue, P., Cuadrado, M. J., & Hughes, G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04580-3 · Cited by 96
McCarthy, E. M., Sutton, E. J., Nesbit, S., White, J., Parker, B., Jayne, D. R. W., Griffiths, B., Isenberg, D. A., Rahman, A., Gordon, C., et al. (2017) · Rheumatology · doi:10.1093/rheumatology/kex395 · Cited by 96
Immunomodulators in SLE: Clinical evidence and immunologic actions
Durcan, L., & Petri, M. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.06.010 · Cited by 92
Self-citationSciascia, S., Branch, D. W., Levy, R. A., Middeldorp, S., Pavord, S. R., Roccatello, D., Ruiz‐Irastorza, G., Tincani, A., Khamashta, M. A., Schreiber, K. I., et al. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-06-0491 · Cited by 85
Epidemiology of systemic lupus erythematosus in rural Wisconsin
Naleway, A. L., Davis, M. E., Greenlee, R. T., et al. (2005) · Lupus · doi:10.1191/0961203305lu2182xx · Cited by 83
See, L., Kuo, C., Chou, I., Chiou, M., & Yu, K. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.06.001 · Cited by 81
ISLAM, M. N., HOSSAIN, M., Haq, S. A., Alam, M. N. A., ten Klooster, P. M., & Rasker, J. J. (2011) · International Journal of Rheumatic Diseases · doi:10.1111/j.1756-185x.2011.01665.x · Cited by 81
Williams, H. J., Egger, M. J., Singer, J. Z., Willkens, R. F., KALUNIAN, K. C., Clegg, D. O., Skosey, J. L., Brooks, R. H., Alarcón, G. S., & Steen, V. D. (1994) · PubMed · Cited by 80
Flower, C., Hennis, A. J. M., Hambleton, I. R., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21656 · Cited by 79
Epidemiology of systemic lupus erythematosus in northwest Greece 1982-2001.
Alamanos, Y., Voulgari, P. V., Siozos, C., et al. (2003) · PubMed · Cited by 78
Davidson, J. E., Fu, Q., Ji, B., Rao, S., Roth, D. A., Magder, L. S., & Petri, M. (2018) · The Journal of Rheumatology · doi:10.3899/jrheum.161554 · Cited by 76
Self-citationLo, M. S. (2016) · Current Rheumatology Reports · doi:10.1007/s11926-016-0621-9 · Cited by 76
Bruce, I. N., Gladman, D., & Urowitz, M. B. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200012)13:6<406::aid-art11>3.0.co;2-2 · Cited by 75
Mok, C., To, C., Yu, K., & Ho, L. (2013) · Lupus · doi:10.1177/0961203313502864 · Cited by 74
Illei, G. G., Cervera, R., Burt, R. K., Doria, A., Hiepe, F., Jayne, D. R. W., Pavletic, S. Z., Martin, T., Marmont, A. M., Saccardi, R., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.148049 · Cited by 72
The use of methotrexate in steroid‐resistant systemic lupus erythematosus
Rothenberg, R. J., Graziano, F. M., Grandone, J. T., Goldberg, J. W., BJARNASON, D. F., & Finesilver, A. G. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310505 · Cited by 71
Efficacy of mycophenolate mofetil in antimalarial-resistant cutaneous lupus erythematosus
Gammon, B., Hansen, C., & Costner, M. I. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.08.011 · Cited by 71
Incidence and prevalence of adult systemic lupus erythematosus in a large US managed-care population
Furst, D. E., Clarke, A., Fernandes, A., et al. (2012) · Lupus · doi:10.1177/0961203312463110 · Cited by 70
Gansauge, S., Breitbart, A., Rinaldi, N., & Schwarz-Eywill, M. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.6.382 · Cited by 68
Braunstein, I., Goodman, N. G., Rosenbach, M. A., Okawa, J., Shah, A., Krathen, M., Kovarik, C., Prak, E. T. L., & Werth, V. P. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.01.015 · Cited by 63
Golder, V., Kandane‐Rathnayake, R., Hoi, A. Y.-B., Huq, M. M., Louthrenoo, W., An, Y., Li, Z. G., Luo, S., Sockalingam, S., Lau, C. S., et al. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1163-2 · Cited by 63
Gleicher, N., & Elkayam, U. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.04.006 · Cited by 62
The role of T cells in systemic lupus erythematosus
Konya, C., Paz, Z., & Tsokos, G. C. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000082 · Cited by 60
Petri, M., Brodsky, R. A., Jones, R. J., Gladstone, D. E., Fillius, M., & Magder, L. S. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27371 · Cited by 54
Self-citationChalmers, S. A., Wen, J., Doerner, J., Stock, A. D., Cuda, C. M., Makinde, H. M., Perlman, H., Bosanac, T., Webb, D., Nabozny, G. H., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1500-0 · Cited by 54
High incidence and prevalence of systemic lupus erythematosus in Norway
Lerang, K., Gilboe, I.-M., Garen, T., Thelle, D. S., & Jt, G. (2012) · Lupus · doi:10.1177/0961203312458168 · Cited by 51
Hartkamp, A., Geenen, R., Godaert, G. L. R., Bijl, M., Bijlsma, J. W. J., & Derksen, R. H. W. M. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.117036 · Cited by 51
Sánchez‐Guerrero, J., Fragoso-Loyo, H. E., Neuwelt, C. M., Wallace, D. J., Ginzler, E. M., Sherrer, Y., McIlwain, H. H., Freeman, P. G., Aranow, C. B., Petri, M., et al. (2005) · PubMed · Cited by 50
Self-citationDiscovery of a novel genetic susceptibility locus on X chromosome for systemic lupus erythematosus
Zhu, Z., Liang, Z., Liany, H., Yang, C., Wen, L., Lin, Z., Sheng, Y., Lin, Y., Ye, L., Cheng, Y., et al. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0857-1 · Cited by 48
A 2 year, open ended trial of methotrexate in systemic lupus erythematosus.
Wilson, K., & Abeles, M. (1994) · PubMed · Cited by 48
Variations in the epidemiology of systemic lupus erythematosus in southern Sweden
Ingvarsson, R. F., Bengtsson, A. A., & Jönsen, A. (2016) · Lupus · doi:10.1177/0961203316635288 · Cited by 47
Kong, W., Deng, W., Sun, Y., Huang, S., Zhang, Z., Shi, B., Chen, W., Tang, X., Yao, G., Feng, X., et al. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3717-3 · Cited by 47
Nasonov, E. L., Soloviev, S. K., Davidson, J., et al. (2013) · Lupus · doi:10.1177/0961203313512881 · Cited by 43
HM71224, a selective Bruton’s tyrosine kinase inhibitor, attenuates the development of murine lupus
Kim, Y.-Y., Park, K. T., Jang, S. Y., Lee, K. H., Byun, J., Suh, K. H., Lee, Y., Kim, Y., & Hwang, K. W. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1402-1 · Cited by 43
Complete complement deficiency in a large cohort of familial systemic lupus erythematosus
Aggarwal, R., Sestak, A., D'Sousa, A., Dillon, S., Namjou, B., & Scofield, R. (2009) · Lupus · doi:10.1177/0961203309346508 · Cited by 36
Ikeuchi, H., Hiromura, K., Takahashi, S., Mishima, K., Sakurai, N., Sakairi, T., Kaneko, Y., Maeshima, A., Kuroiwa, T., & Nojima, Y. (2013) · Modern Rheumatology · doi:10.3109/14397595.2013.844397 · Cited by 31
Eberhardson, M., Hall, S., Papp, K. A., Sterling, T. M., Stek, J. E., Pang, L., Zhao, Y., Parrino, J., & Popmihajlov, Z. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix484 · Cited by 31
Tsioni, V., Andréoli, L., Meini, A., et al. (2015) · PubMed · Cited by 17
Cited by
Tian, J., Zhang, D., Yao, X., Huang, Y., & Lu, Q. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223035 · Cited by 620
Autoimmunity and organ damage in systemic lupus erythematosus
Tsokos, G. C. (2020) · Nature Immunology · doi:10.1038/s41590-020-0677-6 · Cited by 580
Epstein-Barr Virus and Systemic Autoimmune Diseases
Houen, G., & Trier, N. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.587380 · Cited by 379
Song, Y., Li, J., & Wu, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01952-8 · Cited by 259
Teng, Y., Yan, Z.-Y., Wang, L.-L., Wang, Y.-H., Zhang, T.-Y., Li, Z., Liu, S., Cai, J., Chen, Y.-F., Li, M., et al. (2022) · Rheumatology · doi:10.1093/rheumatology/keab806 · Cited by 5
Metadata
- Authors
- Durcan, L., O'Dwyer, T., & Petri, M.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 393
- Issue
- 10188
- Pages
- 2332-2343
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2948214599
- Cited by
- 648
- References
- 143
- FWCI
- 40.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.